A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy

Clinical trial NCT01125748 · COMPLETED

Trial details

NCT number: NCT01125748
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Allergic Asthma

Start date: 2010-05-01
Primary completion: 2013-08-01
Enrollment: 176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.